A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer
Clinical trial NCT01967875 · TERMINATED
Trial details
- NCT number
- NCT01967875
- Sponsor
- China Medical University, China
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-05-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.